Neuroblastoma : : Current State and Recent Updates / / edited by Chandrika Gowda.

Neuroblastoma (NBL) is the most common extracranial solid tumor of childhood, with about 700 new cases of neuroblastoma seen each year in the United States. The 5-year survival rate for children with high-risk NBL is only 50-60%, and this survival rate has not improved over the last 10 years. High-r...

Full description

Saved in:
Bibliographic Details
:
TeilnehmendeR:
Place / Publishing House:Rijeka, Croatia : : IntechOpen,, 2017.
©2017
Year of Publication:2017
Language:English
Physical Description:1 online resource (166 pages) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 00998nam a2200301 i 4500
001 993545601504498
005 20221015211116.0
006 m o d
007 cr |||||||||||
008 221015s2017 ci a o 000 0 eng d
020 |a 953-51-4619-X 
020 |a 953-51-3584-8 
035 |a (CKB)4970000000099634 
035 |a (NjHacI)994970000000099634 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/54495 
035 |a (EXLCZ)994970000000099634 
040 |a NjHacI  |b eng  |e rda  |c NjHacl 
041 0 |a eng 
050 4 |a RD651  |b .N487 2017 
082 0 4 |a 616.994  |2 23 
100 1 |a Chandrika Gowda  |4 auth 
245 0 0 |a Neuroblastoma :  |b Current State and Recent Updates /  |c edited by Chandrika Gowda. 
246 |a Neuroblastoma 
260 |b IntechOpen  |c 2017 
264 1 |a Rijeka, Croatia :  |b IntechOpen,  |c 2017. 
264 4 |c ©2017 
300 |a 1 online resource (166 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 |a Description based on: online resource; title from PDF information screen (InTech, viewed October 15, 2022). 
520 |a Neuroblastoma (NBL) is the most common extracranial solid tumor of childhood, with about 700 new cases of neuroblastoma seen each year in the United States. The 5-year survival rate for children with high-risk NBL is only 50-60%, and this survival rate has not improved over the last 10 years. High-risk patients receive multimodality treatment, including chemotherapy, surgery, radiation therapy, biologic therapy and immunotherapy, all of which are associated with significant morbidity. Recent years have seen many advances in treatment of neuroblastoma, including therapeutic MIBG, immunotherapy, and personalized targeted therapy based on the genetic alterations seen in the tumor. The primary objective of this book is to provide the readers with a comprehensive review of neuroblastoma, from clinical aspects and the currently available treatment to recent advancements and future directions in the field of NBL treatment. The topics and chapters have been compiled keeping in mind a diverse group of readers in different areas of specialty such as pediatric oncology, surgery, radiation oncology, and immunology, as well as physician scientists and basic researchers working in the field of neuroblastoma. 
546 |a English 
650 0 |a Tumors. 
653 |a Medicine 
653 |a Neuro-Oncology 
653 |a Oncology 
653 |a Health Sciences 
776 |z 953-51-3583-X 
700 1 |a Gowda, Chandrika,  |e editor. 
906 |a BOOK 
ADM |b 2023-02-22 20:13:23 Europe/Vienna  |f system  |c marc21  |a 2019-04-13 22:04:18 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5351628430004498&Force_direct=true  |Z 5351628430004498  |b Available  |8 5351628430004498